This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Veronique Bolduc: Innovator in Genetic Disorders
Introduction
Veronique Bolduc is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of genetics, particularly in diagnosing and treating COL6-related disorders. Her innovative work has the potential to impact many lives by identifying individuals at risk for these disorders.
Latest Patents
Veronique Bolduc holds a patent for "Diagnosing COL6-related disorders and methods for treating same." This patent focuses on a single nucleotide polymorphism (SNP) that leads to the development of a Type VI collagen, alpha 1 chain-related disorder. The patent also outlines the use of this SNP to identify individuals at risk for developing COL6-related disorders (COL6-RD). Additionally, it provides antisense oligomers for treating individuals at risk for COL6-RD, along with methods for screening compounds that may serve as therapeutic agents.
Career Highlights
Bolduc works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her role in this esteemed organization highlights her commitment to advancing health and medical research. With her expertise, she has contributed to the understanding and treatment of genetic disorders.
Collaborations
Veronique Bolduc has collaborated with notable professionals in her field, including Francesco Muntoni and Monkol Lek. These partnerships have further enhanced her research and innovation in genetic disorders.
Conclusion
Veronique Bolduc is a trailblazer in the field of genetics, with her patent and collaborative efforts paving the way for advancements in diagnosing and treating COL6-related disorders. Her work exemplifies the impact of innovation in healthcare and the importance of identifying genetic risks.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
